Anthony Mimms, MD
Physical Medicine & Rehabilitation · Indianapolis, INNPI 1952383887
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Kaleo, Inc. at 30.0% of the total. Reporting peaked in 2019 at $3,716 and has fallen 95.5% since, to $167 in 2025. Among physical medicine & rehabilitation clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 381 payments — averaging $26.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kaleo, Inc.$3K
- Redhill Biopharma Inc.$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Collegium Pharmaceutical, Inc.$638
- Amgen$577
- AbbVie$520
- plus $3K from 30 others
What the payments were for
- Consulting fees$1,22512%
- Speaking & faculty fees$2,58525%
- Travel & lodging$1,29313%
- Food & beverage$5,07250%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kaleo, Inc. | 9 | $3,059 |
| Redhill Biopharma Inc. | 9 | $1,685 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 110 | $1,141 |
| Collegium Pharmaceutical, Inc. | 52 | $638 |
| Amgen(2 entities) | 35 | $577 |
| AbbVie(2 entities) | 37 | $520 |
| MDD US Operations, LLC | 1 | $500 |
| Arbor Pharmaceuticals, Inc. | 22 | $267 |
| GRT US Holding, Inc. | 13 | $259 |
| Pfizer | 14 | $236 |
| Eisai Inc. | 9 | $189 |
| Lilly USA, LLC | 9 | $129 |
| Orexo US, Inc. | 8 | $115 |
| Indivior Inc. | 6 | $92 |
| Supernus Pharmaceuticals, Inc. | 6 | $86 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $64 |
| Scilex Pharmaceuticals Inc. | 4 | $59 |
| Vertical Pharmaceuticals, LLC | 3 | $58 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Azurity Pharmaceuticals, Inc. | 2 | $49 |
| Tersera Therapeutics LLC | 2 | $46 |
| Biodelivery Sciences International, Inc. | 3 | $45 |
| Almatica Pharma LLC | 3 | $41 |
| Virtus Pharmaceuticals LLC | 2 | $36 |
| Smith+Nephew | 2 | $34 |
| Boston Scientific | 2 | $30 |
| Daiichi Sankyo Inc. | 2 | $26 |
| IBSA Pharma Inc. | 1 | $24 |
| Shionogi Inc | 2 | $23 |
| Harmony Biosciences LLC | 1 | $20 |
| Abbott | 1 | $19 |
| Si-bone, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Kerecis Limited | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,187 in reported general payments places this provider in the 90th percentile of 140 physical medicine & rehabilitation providers in Indiana.
See all physical medicine & rehabilitation providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PercocetOxycodone Hcl/Acetaminophen | 37 | $182,655 |
| SublocadeBuprenorphine | 25 | $49,941 |
| Xtampza ErOxycodone Myristate | 105 | $48,350 |
| RelistorMethylnaltrexone Bromide | 14 | $31,869 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,046 | $30,806 |
| OxycontinOxycodone Hcl | 41 | $25,647 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 697 | $22,988 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $16,871 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 99 | $15,147 |
| Morphine Sulfate ErMorphine Sulfate | 500 | $12,085 |
| MovantikNaloxegol Oxalate | 22 | $12,030 |
| Cyclobenzaprine Hcl ErCyclobenzaprine Hcl | 21 | $11,810 |
| Oxycodone Hcl | 406 | $8,976 |
| Fentanyl | 62 | $7,485 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 106 | $4,407 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Sublocade, Suboxone | $92 | $66,81244 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $638 | $48,350105 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,141 | $31,86914 claims |
| Redhill Biopharma Inc.Movantik | $1,685 | $12,03022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 140 physical medicine & rehabilitation providers in Indiana.
Other physical medicine & rehabilitation in Indianapolis
- Shashank DaveIndianapolis$198K
- Sachin MehtaIndianapolis$60K
- Flora HammondIndianapolis$9K
- Eric AitkenIndianapolis$5K
- Kyle MazellanIndianapolis$2K
- Abhishek ReddyIndianapolis$2K
- Dianne LeachIndianapolis$2K
- Raghu MaddelaIndianapolis$2K
- Anand NavarasalaIndianapolis$2K
- Shiva GangadharIndianapolis$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.